Effects of bacterial endotoxin on human cross-linked and native hemoglobins.
Previous investigations have demonstrated that hemoglobin (Hb) is a binding protein for bacterial endotoxin (lipopolysaccharide, LPS) and that the structure and biological activity of LPS are altered in the presence of Hb. In the present study, the influence of LPS on the structure of native human HbA0 and covalently cross-linked Hb (alpha alpha Hb) was studied by analyzing the absorption and circular dichroic spectra of Hb in the wavelength region of 200-650 nm. Incubation of oxyHb with each of several LPSs resulted in a decrease in the intensity of the major Soret band at 414 nm with a shift in the maximum peak to 410 nm, decreases in the intensities of the major visible region peaks at 541 and 577 nm, and the appearance of increased absorbance in the visible region in the range of 630 nm. The resultant spectra are characteristic of methemoglobin formation. These spectral changes were time-dependent and LPS-concentration-dependent. Production of methemoglobin was prominent with chemically modified, partially deacetylated rough LPS, and was observed to a lesser extent both with native, complete rough and with native smooth LPSs. The influence of LPS on the absorption spectrum of methemoglobin also was directly tested. The conversion of methemoglobin to hemichrome in the presence of LPS was demonstrated and was shown to be reversible. Analysis of circular dichroic spectra of Hb demonstrated LPS-induced spectral changes in the visible and Soret regions consistent with the production of a substantial quantity of metHb, but did not demonstrate any alteration in the far-UV region (210-240 nm). Moreover, Hb oxygen affinity was only slightly altered after incubation with any of several LPSs. In conclusion, analyses of absorption and circular dichroic spectra reveal the potential of LPS to produce a facilitated oxidation of both alpha alpha-cross-linked human Hb and native human HbA0, without substantial changes in the secondary structure of the globin.
Kaca
W
W
Department of Laboratory Medicine, University of California School of Medicine, San Francisco, USA.
Roth
R I
RI
Vandegriff
K D
KD
Chen
G C
GC
Kuypers
F A
FA
Winslow
R M
RM
Levin
J
J
D001427:Bacterial Toxins / Q000633:toxicity; D001802:Blood Substitutes; D002942:Circular Dichroism; D003432:Cross-Linking Reagents; D004731:Endotoxins / Q000633:toxicity; D006454:Hemoglobins / Q000737:chemistry* / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008070:Lipopolysaccharides / Q000633:toxicity*; D008706:Methemoglobin / Q000737:chemistry / Q000187:drug effects; D010084:Oxidation-Reduction; D011485:Protein Binding; D017433:Protein Structure, Secondary; D013053:Spectrophotometry
D001427:Bacterial Toxins; D001802:Blood Substitutes; D003432:Cross-Linking Reagents; D004731:Endotoxins; D006454:Hemoglobins; D008070:Lipopolysaccharides; D008706:Methemoglobin